CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Cai, Xiaolan ^a,b   Wang, Jian ^a   Xin, Xiaoyan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The Second sanatorium of Jinan Military area   (China)

Author keywords

CIAPIN1; Epithelial ovarian cancer; Nuclear localization; Prognosis

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CYTOKINE INDUCED APOPTOSIS INHIBITOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CELLULAR DISTRIBUTION; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

ADULT; AGED; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84862280896     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-112     Document Type: Article

References (29)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin 2001, 51:15-36. 10.3322/canjclin.51.1.15, 11577478.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
4. Shibayama H, Takai E, Matsumura I, Kouno M, Morii E, Kitamura Y, Takeda J, Kanakura Y. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 2004, 199:581-592. 10.1084/jem.20031858, 2211823, 14970183.
5. Hao Z, Li X, Qiao T, Zhang J, Shao X, Fan D. Distribution of CIAPIN1 in normal fetal and adult human tissues. J Histochem Cytochem 2006, 54:417-426. 10.1369/jhc.5A6753.2005, 16314443.
6. Yan K, He LJ, Cheng W, Ji ZZ, Zhao BX, Hui XL, Cao SS, Chen B, He L, Liang SH, Miao Y. Inhibiting gastric cancer-associated angiogenesis by CIAPIN1 siRNA. Cancer Biol Ther 2009, 8:1058-1063. 10.4161/cbt.8.11.8795, 19502810.
7. Hao Z, Li X, Qiao T, Du R, Zhang G, Fan D. Subcellular localization of CIAPIN1. J Histochem Cytochem 2006, 54:1437-1444. 10.1369/jhc.6A6960.2006, 16957168.
8. Li X, Pan Y, Fan R, Jin H, Han S, Liu J, Wu K, Fan D. Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 2008, 29:1587-1593. 10.1093/carcin/bgn052, 2516489, 18299278.
9. Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R, Chiang JH, Hood L, Clarke MF, Weissman IL. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A 2009, 106:3396-3401. 10.1073/pnas.0900089106, 2642659, 19218430.
10. Zhou J, Zhang L, Gu Y, Li K, Nie Y, Fan D, Feng Y. Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA. World J Surg Oncol 2011, 9:172. 10.1186/1477-7819-9-172, 3258196, 22195770.
11. Kang W, Tong JH, Chan AW, Lee TL, Lung RW, Leung PP, So KK, Wu K, Fan D, Yu J, et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear expression associates with poor prognosis. Clin Cancer Res 2011, 17:2130-2139. 10.1158/1078-0432.CCR-10-2467, 21346147.
12. Hao Z, Qiao T, Jin X, Li X, Gao J, Fan D. Preparation and characterization of a specific monoclonal antibody against CIAPIN1. Hybridoma (Larchmt) 2005, 24:141-145.
13. Wang M, Wang J, Wang L, Wu L, Xin X. Notch1 expression correlates with tumor differentiation status in ovarian carcinoma. Med Oncol 2010, 27:1329-1335. 10.1007/s12032-009-9384-8, 20012562.
14. Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Biochem Cell Biol 2007, 85:741-750. 10.1139/O07-141, 18059532.
15. Shizusawa T, Shibayama H, Murata S, Saitoh Y, Sugimoto Y, Matsumura I, Ogawa H, Sugiyama H, Fukuhara S, Hino M, et al. The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients. Leuk Lymphoma 2008, 49:113-121. 10.1080/10428190701713697, 18203020.
16. McConnell BV, Koto K, Gutierrez-Hartmann A. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer 2011, 10:75. 10.1186/1476-4598-10-75, 3131252, 21682918.
17. Sullivan S, Tosetto M, Kevans D, Coss A, Wang L, O'Donoghue D, Hyland J, Sheahan K, Mulcahy H, O'Sullivan J. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer. Int J Cancer 2009, 125:54-61. 10.1002/ijc.24275, 19291794.
18. Sawhney M, Matta A, Macha MA, Kaur J, DattaGupta S, Shukla NK, Ralhan R. Cytoplasmic expression of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer 2009, 124:2098-2105. 10.1002/ijc.24192, 19142865.
19. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436. 10.1038/nature04870, 16724054.
20. Li X, Wu K, Fan D. CIAPIN1 as a therapeutic target in cancer. Expert Opin Ther Targets 2010, 14:603-610. 10.1517/14728221003774127, 20367238.
21. He L, Wang H, Jin H, Guo C, Xie H, Yan K, Li X, Shen Q, Qiao T, Chen G, et al. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 2009, 276:88-94. 10.1016/j.canlet.2008.10.044, 19081179.
22. Saito Y, Shibayama H, Tanaka H, Tanimura A, Kanakura Y. A cell-death-defying factor, anamorsin mediates cell growth through inactivation of PKC and p38MAPK. Biochem Biophys Res Commun 2011, 405:303-307. 10.1016/j.bbrc.2011.01.033, 21219862.
23. Rosen DG, Yang G, Deavers MT, Malpica A, Kavanagh JJ, Mills GB, Liu J. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer 2006, 106:1925-1932. 10.1002/cncr.21767, 16568440.
24. Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res 2004, 10:5168-5177. 10.1158/1078-0432.CCR-03-0751, 15297421.
25. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512. 10.1101/gad.13.12.1501, 10385618.
26. Resnitzky D, Reed SI. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 1995, 15:3463-3469. 230582, 7791752.
27. Saito Y, Shibayama H, Tanaka H, Tanimura A, Matsumura I, Kanakura Y. PICOT is a molecule which binds to anamorsin. Biochem Biophys Res Commun 2011, 408:329-333. 10.1016/j.bbrc.2011.04.033, 21513700.
28. Wang Y, Mo X, Piper MG, Wang H, Parinandi NL, Guttridge D, Marsh CB. M-CSF Induces Monocyte Survival by Activating NF-kappaB p65 Phosphorylation at Ser276 via Protein Kinase C. PLoS One 2011, 6:e28081. 10.1371/journal.pone.0028081, 3245220, 22216091.
29. Clark CS, Konyer JE, Meckling KA. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Exp Cell Res 2004, 294:301-311. 10.1016/j.yexcr.2003.11.013, 14980523.